dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | García-Montolio, Marc |
dc.contributor.author | Ballaré, Cecilia |
dc.contributor.author | Blanco, Enrique |
dc.contributor.author | Gutiérrez, Arantxa |
dc.contributor.author | Aranda, Sergi |
dc.contributor.author | Gomez Moruno, Antonio |
dc.date.accessioned | 2021-12-16T12:38:01Z |
dc.date.available | 2021-12-16T12:38:01Z |
dc.date.issued | 2021-04-29 |
dc.identifier.citation | García-Montolio M, Ballaré C, Blanco E, Gutiérrez A, Aranda S, Gómez A, et al. Polycomb Factor PHF19 Controls Cell Growth and Differentiation Toward Erythroid Pathway in Chronic Myeloid Leukemia Cells. Front Cell Dev Biol. 2021 Apr 29;9:665201. |
dc.identifier.issn | 2296-634X |
dc.identifier.uri | https://hdl.handle.net/11351/6701 |
dc.description | Leucèmia mieloide crònica; Diferenciació eritroïdal; Polycomb |
dc.description.sponsorship | This work was supported by the Di Croce Laboratory is supported by grants from the Spanish Ministry of Science and Innovation (BFU2016-75008-P and PID2019-108322GB-100), “Fundación Vencer El Cancer” (VEC), the European Regional Development Fund (FEDER), and from AGAUR (SGR 2017-2019). We acknowledge the support of the Spanish Ministry of Science and Innovation to the EMBL partnership, the Centro de Excelencia Severo Ochoa and the CERCA Programme/Generalitat de Catalunya. PV was supported by the Fundación Científica de la Asociación Española Contra el Cáncer. SA was funded by the Ramon y Cajal program of the Ministerio de Ciencia, Innovación y Universidades, the European Social Fund under the reference number RYC-2018-025002-I, and the Instituto de Salud Carlos III-FEDER (PI19/01814). |
dc.language.iso | eng |
dc.publisher | Frontiers Media |
dc.relation.ispartofseries | Frontiers in Cell and Developmental Biology;9 |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Leucèmia mieloide crònica - Tractament |
dc.subject | Regulació genètica |
dc.subject.mesh | Leukemia, Myeloid |
dc.subject.mesh | /therapy |
dc.subject.mesh | Gene Expression Regulation, Neoplastic |
dc.title | Polycomb Factor PHF19 Controls Cell Growth and Differentiation Toward Erythroid Pathway in Chronic Myeloid Leukemia Cells |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.3389/fcell.2021.655201 |
dc.subject.decs | leucemia mieloide |
dc.subject.decs | /terapia |
dc.subject.decs | regulación de la expresión génica neoplásica |
dc.relation.publishversion | https://doi.org/10.3389/fcell.2021.655201 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [García-Montolio M, Ballaré C, Blanco E, Gutiérrez A, Aranda S] Epigenetics Events in Cancer Laboratory, Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology, Barcelona, Spain. [Gómez A] Grup de Recerca en Reumatologia, Servei de Reumatologia, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain |
dc.identifier.pmid | 33996816 |
dc.identifier.wos | 000649663800001 |
dc.relation.projectid | info:eu-repo/grantAgreement/ES/PE2013-2016/BFU2016-75008-P |
dc.relation.projectid | info:eu-repo/grantAgreement/ES/PE2017-2020/PID2019-108322GB-100 |
dc.relation.projectid | info:eu-repo/grantAgreement/ES/PE2017-2020/PI19%2F01814 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |